Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
dry powder inhaler
Pharma
Insmed's phase 2 PAH win sends stock soaring
The company's treprostinil palmitil inhalation powder is a prodrug of United Therapeutics' blockbuster PAH mainstay Tyvaso.
Zoey Becker
Jun 10, 2025 11:59am
Chiesi unveils €430M investment in new Italian inhaler facility
Mar 27, 2025 10:47am
Aptar takes up option on Orbital high dose dry powder inhaler
Aug 9, 2022 10:07am
RLS bags $10M to trial dry powder inhaled CBD in anxiety
Apr 12, 2022 8:00am
Lung safety review delays FDA decision on United's Tyvaso DPI
Mar 1, 2022 10:01am
